drugset / Trial / NCT03555123
Evaluate the Efficacy and Safety of Short-term Administration of SIMDAX
RandomizedParallel-groupDouble-blindTreatment
Summary
A randomized, double-blind, Multicenter, parallel, placebo-controlled study
Timeline
- Start
- 2019-01-11
- Primary completion
- 2022-01-30
- Completion
- 2022-07-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Levosimendan | Other / unclassified | 2.5 mg/ml | Intravenous |